Tech Company Inital Public Offerings

Celladon IPO

Celladon was bought by . Shares started trading on 1/30/2014.

Transaction Overview

Company Name
Announced On
1/30/2014
Transaction Type
IPO
Amount
$44,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12760 High Bluff Dr. 240
San Diego, CA 92130
USA
Email Address
Overview
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology.
Profile
Celladon LinkedIn Company Profile
Social Media
Celladon Company Twitter Account
Company News
Celladon News
Facebook
Celladon on Facebook
YouTube
Celladon on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Krisztina Zsebo
  Krisztina Zsebo LinkedIn Profile  Krisztina Zsebo Twitter Account  Krisztina Zsebo News  Krisztina Zsebo on Facebook
VP - Finance
Rebecque Laba
  Rebecque Laba LinkedIn Profile  Rebecque Laba Twitter Account  Rebecque Laba News  Rebecque Laba on Facebook
VP - General Counsel
Elizabeth Reed
  Elizabeth Reed LinkedIn Profile  Elizabeth Reed Twitter Account  Elizabeth Reed News  Elizabeth Reed on Facebook
VP - Operations
Jeffrey Rudy
  Jeffrey Rudy LinkedIn Profile  Jeffrey Rudy Twitter Account  Jeffrey Rudy News  Jeffrey Rudy on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/30/2014: nextSociety venture capital transaction
Next: 1/30/2014: Enigma venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary